The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

The study highlights the need for more research to focus on African demographics on the continent to personalise treatments ...

ERC Advanced Grants worth a total of €721m were awarded to 281 researchers, with UCD's Prof Kylie Jarrett and Dr Barry Wardell among the winners.

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

Oesophageal adenocarcinoma has an extremely poor prognosis, and improving outcomes via therapy remains particularly challenging in such a heterogeneous cancer. Another avenue for improving outcomes ...

The worse overall survival seen in transgender and gender-diverse patients may be due to treatment differences or non-breast cancer causes, researchers say.

Final analysis of KEYNOTE-A18 showed that pembrolizumab plus concurrent chemoradiation showed sustained PFS/OS benefits in ...

The Motley Fool. DATE Tuesday, June 17, 2025 at 10 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer and Board Chair ...

Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.3 billion in its U.S.

On Thursday, the U.S. House of Representatives advanced Republican budget legislation that would substantially increase the tax on Yale’s endowment investment income — which could limit students’ ...

Extended follow-up data from the CheckMate 274 trial have further solidified adjuvant nivolumab’s position as a standard of ...